Candice Long ’94 is president of infectious diseases and vaccines for Johnson & Johnson’s pharmaceutical division, Janssen. She and the “incredible” teams she leads have been at the forefront of the effort to produce the first single-shot vaccine for COVID-19, which received FDA emergency use authorization this past weekend.
When one of the nation’s top spots in infectious diseases opened up last June, Candice Malone Long ’94 didn’t think twice. For the chance to help when the world was facing a raging pandemic and in need of vaccines and therapeutics?
“It was an absolute ‘yes,’ ” said Long, who has spent 25 years with Johnson & Johnson, the world’s broadest and most diversified healthcare company, and its pharmaceutical division, Janssen. Her tenacity – and the work of the “incredible” teams she leads – supported a pivotal moment this past weekend with FDA Emergency Use Authorization of the first single-shot COVID-19 vaccine.
Recruited to Mary Washington to play field hockey, Long burned it up in the classroom and on the turf, earning All-American status in both. As captain, she led her senior-year team to the No. 2 spot in the U.S. and joined the UMW Athletic Hall of Fame, all while earning degrees in business and history with the guidance of faculty who showed her the way.
The leadership style she employs at Janssen took shape in the liberal arts and sciences environment at UMW, she said. She learned the value of raising her hand, taking the lead in initiating discussions to seek solutions, and engaging diverse teams in setting and meeting goals with high expectations. It paved the way for her work at Johnson & Johnson, including preparing for potential Emergency Use Authorization of the company’s investigational COVID-19 vaccine. Read more.
